Rx Safety Bill Produces Restless REMS; Core Of “KEnzi” Is Narrowed But Intact
Executive Summary
The Rx safety oversight system outlined in the legislation passed out of the Senate Health Committee April 18 has a greater focus on active surveillance systems than the bill originally introduced by Sens. Edward Kennedy, D-Mass., and Michael Enzi, R-Wyo
You may also be interested in...
Battle Lines Clear On Conflict Of Interest Policy In PDUFA Reauthorization
Commissioner Hamburg says the agency likely does not need legislation to improve its conflict of interest policy, but House members still say the system needs reform. Industry and patient advocate groups push for change, while consumer groups press FDA to stand firm.
Battle Lines Clear On Conflict Of Interest Policy In PDUFA Reauthorization
Commissioner Hamburg says the agency likely does not need legislation to improve its conflict of interest policy, but House members still say the system needs reform. Industry and patient advocate groups push for change, while consumer groups press FDA to stand firm.
FDA Conflict Of Interest Policy May Be Biggest Conflict Of PDUFA Reauthorization
Commissioner Hamburg says the agency likely does not need legislation to improve its conflict of interest policy, but House members still say system needs reform.